Co-Authors
This is a "connection" page, showing publications co-authored by Nicola Coppola and Rocco Capuano.
Connection Strength
0.300
-
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab. Ther Adv Neurol Disord. 2021; 14:17562864211038111.
Score: 0.240
-
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab. Neurol Sci. 2021 Sep; 42(9):3523-3526.
Score: 0.059